Shiru invites brands to harness its AI platform to explore ‘natural’ GLP-1 activation: ‘The opportunity is immense’ – AgFunderNews
Shiru invites brands to harness its AI platform to explore ‘natural’ GLP-1 activation: ‘The opportunity is immense’ AgFunderNews
STAT+: Eli Lilly drug preserves lean mass in patients losing weight on Wegovy
CHICAGO — An investigational therapy from Eli Lilly helped preserve lean mass and drive greater loss of fat in patients taking the popular obesity treatment Wegovy. In a Phase 2 trial, patients taking the highest-dose combination of Wegovy and the drug, called bimagrumab, lost 22% of their weight at 72 weeks. Ninety-three percent of that […]
Fractyl Health Presents New Data at the American Diabetes Association’s 85th Scientific Sessions Demonstrating its Rejuva ® Smart GLP-1™ Pancreatic Gene Therapy Platform Prevents Obesity and Type
The quiet trends reshaping ag: a field guide for builders, backers, and business leaders
Mark S. Brooks is a venture strategist and corporate innovation leader with deep experience across agtech, biotech, climate, and entrepreneurship. A former academic climate scientist-turned-investor, Mark has deployed over $75 million in venture capital globally, led FMC Ventures, invested at Syngenta Ventures, and founded an agtech startup. While exploring his next senior leadership role, Mark […]
Efficacy and safety of danuglipron (PF‐06882961) in adults with obesity: A randomized, placebo‐controlled, dose‐ranging phase 2b study
Abstract Aims This randomized, double-blind, placebo-controlled Phase 2b study aimed to assess the efficacy, safety, and tolerability of danuglipron (PF-06882961), an oral small-molecule glucagon-like peptide-1 (GLP-1) receptor agonist, in adults with obesity. Materials and Methods Eligible participants (aged 18–75 years; with obesity, without diabetes) were randomized to receive danuglipron or placebo twice daily (BID) for 26 […]
The rise of GLP-1 drugs: Transforming weight loss treatment
Discover how GLP-1 drugs are reshaping weight loss and treatment horizons.
UBS Lowers Price Target On Regeneron Pharmaceuticals, Inc. (REGN).
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is among the 11 Best Genomics Stocks to Buy According to Hedge Funds. UBS has maintained its Neutral rating on Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) and reduced its price objective from $633 to $560 on June 5, noting mixed corporate updates and recent pipeline advancements. A pharmacist in a lab coat carefully […]
Novel GLP-1 Agonist Promotes Safe and Effective Weight Loss – Medscape
Novel GLP-1 Agonist Promotes Safe and Effective Weight Loss Medscape China’s Sciwind’s GLP-1 shows similar weight loss to Novo’s Wegovy, study finds Reuters Chinese Biotech Showcases Challenger to Eli Lilly’s Obesity Drug Bloomberg SLIMMER: Ecnoglutide Demonstrates Weight Loss Potential in Phase 3 Trial HCPLive China, where obesity levels are low, becomes hotbed for weight loss drug trials STAT
Decision on merger with Biocon Biologics soon, says Siddharth Mittal
We are talking about the GLP-1 opportunity and our strong franchise in insulins. There is a huge demand in the global diabetes-obesity segment, said Siddharth Mittal